| Product Code: ETC6557259 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Bulgaria`s import of pyruvate kinase in 2024 saw a diverse range of countries contributing, with Japan, Denmark, China, Belgium, and Metropolitan France emerging as the top exporters. Despite a negative CAGR of -9.7% from 2020 to 2024, there was a slight growth uptick in 2024 with a rate of 1.15%. The Market Top 5 Importing Countries and Market Competition (HHI) Analysis concentration, as measured by the HHI, remained at a moderate level, indicating a balanced distribution of imports among the key exporting nations. Continued monitoring of these trends will be crucial for stakeholders in the pyruvate kinase Market Top 5 Importing Countries and Market Competition (HHI) Analysis .

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Pyruvate Kinase Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Bulgaria Pyruvate Kinase Market - Industry Life Cycle |
3.4 Bulgaria Pyruvate Kinase Market - Porter's Five Forces |
3.5 Bulgaria Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Bulgaria Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Bulgaria |
4.2.2 Growing awareness about genetic disorders and the importance of early diagnosis |
4.2.3 Technological advancements in diagnostic tools and treatment options for pyruvate kinase deficiency |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for pyruvate kinase deficiency treatment in Bulgaria |
4.3.2 High costs associated with genetic testing and treatment for pyruvate kinase deficiency |
5 Bulgaria Pyruvate Kinase Market Trends |
6 Bulgaria Pyruvate Kinase Market, By Types |
6.1 Bulgaria Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Bulgaria Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Bulgaria Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Bulgaria Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Bulgaria Pyruvate Kinase Market Export to Major Countries |
7.2 Bulgaria Pyruvate Kinase Market Imports from Major Countries |
8 Bulgaria Pyruvate Kinase Market Key Performance Indicators |
8.1 Number of new cases diagnosed annually |
8.2 Adoption rate of advanced diagnostic tools for pyruvate kinase deficiency |
8.3 Patient satisfaction with treatment outcomes and quality of life improvements |
9 Bulgaria Pyruvate Kinase Market - Opportunity Assessment |
9.1 Bulgaria Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Bulgaria Pyruvate Kinase Market - Competitive Landscape |
10.1 Bulgaria Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Bulgaria Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |